Article
Prognostic Ability of Enhancer RNAs in Metastasis of Non-Small Cell Lung Cancer
26 Jun 2022
Abstract excerpt
(1) Background: Non-small cell lung cancer (NSCLC) is the most common lung cancer. Enhancer RNA (eRNA) has potential utility in the diagnosis, prognosis and treatment of cancer, but the role of eRNAs in NSCLC metastasis is not clear; (2) Methods: Differentially expressed transcription factors (DETFs), enhancer RNAs (DEEs), and target genes (DETGs) between primary NSCLC and metastatic NSCLC were identified....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
